Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cerilliant
Baxter
Harvard Business School
QuintilesIMS
Covington
Merck
Fuji
US Department of Justice

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016211

« Back to Dashboard

NDA 016211 describes MIOCHOL, which is a drug marketed by Novartis and Bausch And Lomb and is included in two NDAs. Additional details are available on the MIOCHOL profile page.

The generic ingredient in MIOCHOL is acetylcholine chloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetylcholine chloride profile page.
Summary for 016211
Tradename:MIOCHOL
Applicant:Novartis
Ingredient:acetylcholine chloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 016211
Cholinergic Agonists
Vasodilator Agents

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:FOR SOLUTION;OPHTHALMICStrength20MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Queensland Health
US Department of Justice
Dow
Julphar
Cipla
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
 
Links

Follow DrugPatentWatch: